Perigon Wealth Management LLC Sells 130 Shares of Teladoc Health Inc (NYSE:TDOC)

Perigon Wealth Management LLC decreased its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 7.4% in the second quarter, HoldingsChannel reports. The institutional investor owned 1,630 shares of the health services provider’s stock after selling 130 shares during the period. Perigon Wealth Management LLC’s holdings in Teladoc Health were worth $311,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of TDOC. PrairieView Partners LLC bought a new stake in shares of Teladoc Health in the 1st quarter valued at about $31,000. Pathstone Family Office LLC bought a new stake in shares of Teladoc Health in the 1st quarter valued at about $31,000. Marshall Wace North America L.P. bought a new stake in shares of Teladoc Health in the 1st quarter valued at about $35,000. Capital Advisory Group Advisory Services LLC bought a new stake in shares of Teladoc Health in the 1st quarter valued at about $36,000. Finally, Prime Capital Investment Advisors LLC bought a new stake in shares of Teladoc Health in the 1st quarter valued at about $37,000. Institutional investors and hedge funds own 97.14% of the company’s stock.

TDOC stock opened at $237.63 on Friday. The firm’s fifty day simple moving average is $207.13 and its 200-day simple moving average is $158.76. The company has a quick ratio of 6.14, a current ratio of 6.14 and a debt-to-equity ratio of 0.45. Teladoc Health Inc has a 12 month low of $54.58 and a 12 month high of $240.00.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.11). The business had revenue of $241.03 million during the quarter, compared to analysts’ expectations of $220.49 million. Teladoc Health had a negative net margin of 13.22% and a negative return on equity of 10.23%. The firm’s revenue was up 85.0% on a year-over-year basis. During the same period last year, the company earned ($0.41) earnings per share. On average, equities analysts anticipate that Teladoc Health Inc will post -1.41 EPS for the current fiscal year.

TDOC has been the subject of several recent analyst reports. KeyCorp boosted their price objective on shares of Teladoc Health from $195.00 to $240.00 and gave the stock an “overweight” rating in a research note on Thursday. Argus initiated coverage on shares of Teladoc Health in a research note on Monday, July 13th. They set a “buy” rating and a $280.00 price objective for the company. Cowen reiterated a “buy” rating and set a $197.00 price objective on shares of Teladoc Health in a research note on Wednesday, July 8th. UBS Group boosted their price objective on shares of Teladoc Health from $119.00 to $185.00 and gave the stock a “neutral” rating in a research note on Thursday, April 30th. Finally, Cantor Fitzgerald boosted their price objective on shares of Teladoc Health from $165.00 to $210.00 and gave the stock a “neutral” rating in a research note on Thursday. Fifteen equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Teladoc Health has an average rating of “Hold” and a consensus target price of $195.04.

In related news, insider Adam C. Vandervoort sold 547 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $175.57, for a total value of $96,036.79. Following the completion of the transaction, the insider now directly owns 1,336 shares in the company, valued at approximately $234,561.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William H. Frist sold 740 shares of the business’s stock in a transaction on Friday, July 10th. The shares were sold at an average price of $228.00, for a total transaction of $168,720.00. Following the completion of the transaction, the director now owns 6,158 shares of the company’s stock, valued at $1,404,024. The disclosure for this sale can be found here. Over the last quarter, insiders sold 189,977 shares of company stock valued at $36,248,032. Company insiders own 3.42% of the company’s stock.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Outstanding Shares

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.